PRM36 - Pharmacoeconomic Evaluation of Sorafenib As First-Line Treatment for Advanced Hepatocellular Carcinoma.
Autor: | Naumovska, Z1, Kapedanovska Nestorovska, A1, Grozdanova, A2, Suturkova, L3, Dimovski, A2, Sterjev, Z3 |
---|---|
Zdroj: | Value in Health. Oct2017, Vol. 20 Issue 9, pA736-A736. 1p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |